Amino.Desk

MK-677 (ibutamoren)

Updated Nov 17, 2026 · Clinical review: pending

MK-677, or ibutamoren, is a pill that raises growth hormone. It is not a peptide. It has real human trials, and they are the reason for caution: a small gain in lean mass with no gain in strength, higher blood sugar, and one trial stopped early over heart failure.

What it is

Ibutamoren is a small molecule that imitates ghrelin at the receptor that triggers growth hormone release. Unlike the injectable growth hormone peptides, it works when swallowed. Merck developed it in the 1990s and stopped. Another company has since studied it for growth hormone deficiency in children.

What the evidence shows

The pattern across the trials is consistent: the hormone numbers move, and the outcomes people care about mostly do not.

Legal status

Reported dosing

No approved dose exists.

The dose used in the main trials was 25 mg once a day by mouth, in monitored studies of older adults and patients. That is what was tested. It is not a recommendation, and the hip fracture trial at that dose was the one stopped for safety.

Safety

Common questions

Is MK-677 a peptide?

No. It is a small-molecule drug taken by mouth. It is sold alongside peptides because it raises growth hormone.

Is MK-677 legal?

It is not FDA-approved, and the FDA lists it among substances that may present significant safety risks in compounding.

Does MK-677 build muscle?

In the main trial, fat-free mass rose by 1.1 kg over 12 months, but strength and physical function did not improve.

Why was an MK-677 trial stopped?

A trial in hip fracture patients was ended early because of a heart failure signal in patients taking the drug.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy